UBS Group »

Bicara Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Bicara Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2901M2M3M050k100k150k200k
Value ($)Share countHistorical BCAX position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.5M 200k 17.42
2024-09-30 $71k 2.8k 25.47

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Omega Fund Management
Adage Capital Partners GP
FMR
Braidwell
Deerfield Management Company
T. Rowe Price Associates
Fairmount Funds Management
BlackRock
Vanguard Group
Fil
Blackstone Group
Henderson Group

View all funds holding Bicara Therapeutics